COVID-19 Testing in the Los Angeles Area, Nationwide for Corporate Group Testing
Learn more about our professional in-home COVID-19 Testing services, now available nationwide.
DirectCare Blood Panel Tests
Access key insight into your overall health. DirectCare offers a variety of concierge blood panel testing, spanning from your overall wellness, thyroid health, vitamin levels and more.
Wellness Lab Panel testing
Comprehensive Wellness Panels for Men's, Women, Hormone, and Vitamin levels
RSV and Flu test combo
Testing panel for COVID-19, RSV, FLU A & B Test and STI Testing
Mobile Phlebotomy makes blood draws convenient and quick
Which tests are offered through our partner labs?
Covid-19 Laboratory Developed PCR Test
Thermo Fisher and Ortho Clinical are listed on the FDA Emergency Use Authorization at the FDA website, under FAQs on Diagnostic Testing for SARS-CoV-2.
All swab tests have high sensitivity and high specificity.
SARS-CoV-2 (COVID-19) Antibody, IgG and IgM Tests
Roche and BD are performing the SARS-CoV-2 Antibody, IgG and IgM Tests in combination. Below is some background information on this testing.
After infection with SARS-CoV-2, viral antigens stimulate the body’s immune system to produce antibodies. The virus incubation period and the days/weeks when the antibodies appear in the blood are defined below.
SARS-CoV-2 virus Antibodies, IgM and IgG
- IgM appears early in the blood circulation after an infection (as early as 3-5 days).
- IgG appears later in the blood circulation after an infection (within 3-4 weeks).
"The IgM and IgG tests are able to detect the antibodies to the SARS-CoV-2 virus and the kits have high specificity, sensitivity and clinical agreement with samples confirmed with PCR methods (RT-qPCR)".
COVID-19 Testing In the News
American Heart Association
COVID-19 science: Why testing is so important
"When a communicable disease outbreak begins, the ideal response is for public health officials to begin testing for it early. That leads to quick identification of cases, quick treatment for those people and immediate isolation to prevent spread. Early testing also helps to identify anyone who came into contact with infected people so they too can be quickly treated."
Two Tests That Could Help Contain the COVID-19 Pandemic
“Testing matters from a global and public health standpoint,” says Jasmine Marcelin, an infectious disease physician at the University of Nebraska Medical Center. “This [outbreak] is moving so rapidly. If we don’t have a good understanding of how many people are affected, we will not be able to effectively curb the spread of disease.”
'Immunity passports' could speed up return to work after Covid-19
Prof Peter Openshaw, a member of the government’s new and emerging respiratory virus threats advisory group, said people who have recovered and test positive for coronavirus antibodies should no longer be infectious themselves and would be expected to have at least some immunity to the virus.
The New York Times
F.D.A. Approves First Coronavirus Antibody Test in U.S.
Such a test may help scientists learn how widespread the infection is, and how long people remain immune after recovering.
COVID-19 Antibody Test
The CLIA lab validated diagnostic tests being offered by this site are in accordance with the FDA’s Emergency Use Notification and Authorization process as provided in the FDA’s “Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency” (March 16, 2020) for laboratories certified under CLIA and FDA standards to perform high-complexity testing. Our test’s manufacturing lab has notified the FDA as required and has been listed on the FDA’s website accordingly.
- This test has not been reviewed by the FDA.
- Negative results do not rule out SARS-CoV-2 infection, particularly in those who have been in contact with the virus. Follow-up testing with a molecular diagnostic should be considered to rule out infection in these individuals.
- Results from antibody testing should not be used as the sole basis to diagnose or exclude SARS-CoV-2 infection or to inform infection status.
- Positive results may be due to past or present infection with non-SARS-CoV-2 coronavirus strains, such as coronavirus HKU1, NL63, OC43, or 229E.
- This test is not for the screening of donated blood
COVID-19 PCR Swab Test
The CLIA lab validated diagnostic tests being offered by this site are in accordance with the FDA’s Emergency Use Notification and Authorization process as provided in the FDA’s “Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency” (March 16, 2020) for laboratories certified under CLIA and FDA standards to perform high-complexity testing. Our test’s manufacturing lab has notified the FDA as required and has been listed on the FDA’s website accordingly and received FDA authorization.